Andreas Meyerhans News Today

An international study coordinated by the MELIS-UPF researchers Andreas Meyerhans and Juana Díez has identified Schlafen 12, a new HIV restriction factor that could pave the way for new strategies for curing the infection.

When it comes to the design of a novel vaccine against viral infection, vaccine developers have to make several major decisions. One of them is the choice of what type of immune response they wish to induce.

When it comes to the design of a novel vaccine against viral infection, vaccine developers have to make several major decisions. One of them is the